导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.44% | 537/1050 |
| 近一周 | -2.49% | 629/1104 |
| 近一月 | -5.93% | 712/1102 |
| 近一季 | -9.04% | 624/1092 |
| 近半年 | -1.86% | 471/1070 |
| 近一年 | 3.55% | 501/1018 |
| 近两年 | 41.84% | 562/926 |
| 近三年 | 27.17% | 413/834 |
| 成立以来 | -15.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.28% 574/1070 |
13.09% 494/1101 |
- - |
- - |
| 2025 | 27.30% 526/1065 |
2.84% 558/1014 |
0.71% 634/1038 |
24.16% 469/1050 |
-1.00% 495/1065 |
| 2024 | 8.82% 319/1011 |
4.92% 106/960 |
1.83% 203/983 |
7.37% 804/991 |
-5.14% 678/1011 |
| 2023 | -19.97% 668/952 |
-1.27% 680/880 |
-7.50% 663/895 |
-4.48% 266/915 |
-8.26% 781/952 |
| 2022 | -31.67% 658/867 |
-18.10% 434/773 |
4.66% 540/806 |
-16.80% 672/845 |
-4.19% 606/867 |
| 2021 | -5.03% 415/740 |
-6.05% 385/580 |
8.64% 395/659 |
-9.43% 494/704 |
2.74% 318/740 |
| 2020 | - - |
- - |
- - |
- - |
14.25% 221/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇添富开放视野中国优势六个月持有股票A VS. 东吴新产业精选股票A(580008) |